| PDF - Published Version (109kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-343776
- DOI to cite this document:
- 10.5283/epub.34377
Abstract
Microarray gene expression signatures hold great promise to improve diagnosis and prognosis of disease. However, current documentation standards of such signatures do not allow for an unambiguous application to study-external patients. This hinders independent evaluation, effectively delaying the use of signatures in clinical practice. Data from eight publicly available clinical microarray ...
Owner only: item control page